Notice Information
Notice Title
NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)
Notice Description
Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders. The Condition can be difficult to diagnose because initial presentation can be non-specific and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects Adults. Children are treated in paediatric haematology centres and are outside the scope of this process.
Lot Information
Thrombotic Thrombocytopenic Purpura (TTP) - London and the South East (Kent, Surrey, East & West Sussex)
Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1). The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - West MidlandsThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - East MidlandsThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - East of EnglandThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - North EastThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the HumberThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.
Thrombotic Thrombocytopenic Purpura (TTP) - South WestThrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02a260
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/012086-2021
- Current Stage
- Tender
- All Stages
- Planning, Tender
Procurement Classification
- Notice Type
- Planning Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85000000 - Health and social work services
85100000 - Health services
Notice Value(s)
- Tender Value
- £54,943,200 £10M-£100M
- Lots Value
- £90,943,200 £10M-£100M
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 28 May 20214 years ago
- Submission Deadline
- 25 Jun 2021Expired
- Future Notice Date
- 3 May 2021Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND - SPECIALISED COMMISSIONING)
- Additional Buyers
- Contact Name
- Not specified
- Contact Email
- lisa.innes1@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SE1 6LH
- Post Town
- South East London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI4 Inner London - East
- Small Region (ITL 3)
- TLI44 Lewisham and Southwark
- Delivery Location
- TLC North East (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLJ2 Surrey, East and West Sussex, TLJ4 Kent, TLK South West (England)
-
- Local Authority
- Southwark
- Electoral Ward
- St George's
- Westminster Constituency
- Bermondsey and Old Southwark
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02a260-2021-05-28T17:36:26+01:00",
"date": "2021-05-28T17:36:26+01:00",
"ocid": "ocds-h6vhtk-02a260",
"description": "In response to a recommendation from the Prescribed Specialised Services Advisory Group in 2014, NHS England developed a service model that aimed to balance the high levels of multi-disciplinary expertise required to treat patients with TTP with the requirement for patients to be treated rapidly to have optimal outcomes. NHS England undertook a public consultation on the draft service specification, which closed in October 2018. The consultation documents are still available on the NHS England website at this link: Consultation on service specifications for thrombotic thrombocytopenic purpura (TTP) for all ages - NHS England - Citizen Space. The model of delivery is to offer in-patient care within a specialist TTP centre, Patients with TTP require lifelong monitoring and follow up to manage relapse. Shared care is possible, based on the preference of the patient. Specialist TTP centres are required to undertake a clinical leadership, proactive education and outreach service to hospitals within their region to improve the identification of patients with TTP and the timely referral of patients to the specialist TTP centres. Specialist TTP centres are required to establish robust clinical partnerships with paediatric haematology centres to provide support in relation to the treatment of children and to agree a transition policy. There are patient flows to London from all over the South East. Commissioners have considered establishing one provider for all of London and the South East and this is the default Commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas, (Lot 2)) to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1). This will support effective care and improve local patient access to the service whilst ensuring availability of clinical expertise as appropriate. To register your interest in these services please follow this link https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK and either login or register on EU Supply and search from ID number 43998. All Bidders are asked to complete the general Qualification and Technical questions and the Lot specific Qualification and Technical Questions for the Lots they are applying for. Bidders may apply for more than one Lot, but will only be awarded a maximum of one Lot. Please refer to the Process Selection Process Overview documents for further details.",
"initiationType": "tender",
"tender": {
"id": "NHSSC-TPP-2021- NHS England",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS England Spec. Commissioning - Thrombotic Thrombocytopenic Purpura (TTP) all ages (up to 8 Lots)",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
"mainProcurementCategory": "services",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders. The Condition can be difficult to diagnose because initial presentation can be non-specific and this is a very rare disease. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects Adults. Children are treated in paediatric haematology centres and are outside the scope of this process.",
"lots": [
{
"id": "1",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - London and the South East (Kent, Surrey, East & West Sussex)",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting interested Providers to bid for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. There are patient flows to London from all over the South East. Commissioners have considered establishing one specialist provider for all of London and the South East and this is the default commissioner position. Commissioners will consider bids for the South East (Thames Valley and Hampshire and Isle of Wight areas - (Lot 2)), to facilitate patient choice and to reduce the requirement to travel for providers who meet the criteria in the service specification, in the technical questionnaire and who are willing to work within a Clinical Partnership with the successful bidder for the London and South East Lot (Lot 1). The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": ": Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 20589200,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "2",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - South East (Thames Valley, Hampshire and the Isle of Wight)",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 4173800,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "3",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - West Midlands",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 7633000,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "4",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - East Midlands",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres centre in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": ": Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 4041100,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "5",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - East of England",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 4017500,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "6",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - North East",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years. Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 40002800,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "7",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - Yorkshire and the Humber",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 4851400,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
},
{
"id": "8",
"title": "Thrombotic Thrombocytopenic Purpura (TTP) - South West",
"description": "Thrombotic Thrombocytopenic Purpura (TTP) is a very rare, complex condition which can present as an acute life-threatening disorder that requires prompt diagnosis, early referral and effective immediate management in a centre with comprehensive provision and a multi-discipline approach. Specialist aftercare is also required. There is also a cohort of patients who have a congenital form of the disease who require ongoing apheresis (where a patient's blood is filtered and then put back into their body). The national prevalence is 330 patients in England, with an acute incidence of 150 patients. There is a very high mortality rate for patients with this disease: if a patient is treated outside of a specialist centre, the death rate is 50%. There are currently 2 centres in England where there are recognised services and where the survival rate is 80%. NHS Arden & Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of the Commissioner(s), NHS England - Specialised Commissioning, are looking to commission up to a further 8 Centres across England for TTP services and are inviting bids for these services. The service is a Schedule 3 Service and is being procured under the Light Touch Regime (LTR) of the Public Contract Regulations 2015. The contracting term for these services will be for a period of up to 4 years Additional information: Please note that Lots may have changed from previous publications.",
"status": "active",
"awardCriteria": {
"criteria": [
{
"name": "Section K : Skills and competences",
"type": "quality",
"description": "20"
},
{
"name": "Section L: Managing access and treatment pathway",
"type": "quality",
"description": "42"
},
{
"name": "Section M: Mobilisation",
"type": "quality",
"description": "10"
},
{
"name": "Section N: Education and service continuity",
"type": "quality",
"description": "6"
},
{
"name": "Section O: Clinical outcomes and governance",
"type": "quality",
"description": "7"
},
{
"name": "Section P: Patient satisfaction and patient group",
"type": "quality",
"description": "10"
},
{
"name": "Section Q: Networks and leadership",
"type": "quality",
"description": "5"
},
{
"type": "price",
"description": "0"
}
]
},
"value": {
"amount": 5634400,
"currency": "GBP"
},
"contractPeriod": {
"durationInDays": 1440
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
},
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
}
],
"deliveryAddresses": [
{
"region": "UKJ4"
},
{
"region": "UKJ2"
},
{
"region": "UKI"
},
{
"region": "UKJ4"
},
{
"region": "UKJ2"
},
{
"region": "UKI"
}
],
"deliveryLocation": {
"description": "London and the South East (Kent, Surrey, East & West Sussex)"
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKJ"
},
{
"region": "UKJ"
}
],
"deliveryLocation": {
"description": "South East (Thames Valley, Hampshire and the Isle of Wight)"
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKK"
},
{
"region": "UKG"
}
],
"deliveryLocation": {
"description": "West Midlands"
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKG"
},
{
"region": "UKF"
}
],
"deliveryLocation": {
"description": "East Midlands"
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKF"
},
{
"region": "UKH"
}
],
"deliveryLocation": {
"description": "East of England"
},
"relatedLot": "5"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKH"
},
{
"region": "UKC"
}
],
"deliveryLocation": {
"description": "North East"
},
"relatedLot": "6"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKC"
},
{
"region": "UKE"
}
],
"deliveryLocation": {
"description": "Yorkshire and the Humber"
},
"relatedLot": "7"
},
{
"id": "8",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "85000000",
"description": "Health and social work services"
},
{
"scheme": "CPV",
"id": "85100000",
"description": "Health services"
}
],
"deliveryAddresses": [
{
"region": "UKE"
},
{
"region": "UKK"
}
],
"deliveryLocation": {
"description": "Yorkshire and the Humber"
},
"relatedLot": "8"
}
],
"communication": {
"futureNoticeDate": "2021-05-04T00:00:00+01:00"
},
"value": {
"amount": 54943200,
"currency": "GBP"
},
"lotDetails": {
"maximumLotsAwardedPerSupplier": 1
},
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "https://uk.eu-supply.com/login.asp?B=AGCSU&target=",
"selectionCriteria": {
"criteria": [
{
"type": "technical",
"description": "All technical capacity and its evaluation criteria are specified within the tender documentation.",
"appliesTo": [
"supplier"
]
}
]
},
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2021-06-25T17:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
]
},
"awardPeriod": {
"startDate": "2021-06-25T17:00:00+01:00"
},
"bidOpening": {
"date": "2021-06-25T17:00:00+01:00"
},
"hasRecurrence": false,
"amendments": [
{
"id": "1",
"unstructuredChanges": [
{
"oldValue": {
"text": "Lot 3 - Estimated value Value excluding VAT: 7633000.00 GBP Lot 4 - Estimated value Value excluding VAT: 4041100.00 GBP"
},
"newValue": {
"text": "Lot 3 - Estimated value Value excluding VAT: 6846800.00 GBP Lot 4 - Estimated value Value excluding VAT: 4826500.00 GBP"
},
"where": {
"section": "11.2.6"
},
"relatedLot": "Lot 3 and 4"
}
],
"description": "Commissioners have identified a mapping error in the Population Mapping tab of Document 1a Annex A, which had the population of NHS Derby and Derbyshire CCG included in Lot 3 (West Midlands) when it should have been mapped to Lot 4 (East Midlands). This error has been corrected and Commissioners confirm that both the provider of Derby and Burton Hospital NHS Foundation Trust and the population of NHS Derby and Derbyshire CCG is in Lot 4 (East Midlands)."
}
]
},
"parties": [
{
"id": "GB-FTS-11153",
"name": "NHS England - Specialised Commissioning",
"identifier": {
"legalName": "NHS England - Specialised Commissioning",
"id": "N/A"
},
"address": {
"streetAddress": "80 London Road",
"locality": "London",
"region": "UK",
"postalCode": "SE1 6LH",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "lisa.innes1@nhs.net",
"url": "https://uk.eu-supply.com/ctm/supplier/publictenders?B=UK"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/commissioning/spec-services/",
"buyerProfile": "https://www.ardengemcsu.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-16975",
"name": "NHS England - Specialised Commissioning)",
"identifier": {
"legalName": "NHS England - Specialised Commissioning)"
},
"address": {
"streetAddress": "80 London Road",
"locality": "London",
"region": "UK",
"postalCode": "SE1 6LH",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "lisa.innes1@nhs.net",
"url": "https://uk.eu-supply.com/login.asp?B=AGCSU&target="
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.england.nhs.uk/commissioning/spec-services/",
"buyerProfile": "https://www.ardengemcsu.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-2638",
"name": "Arden & GEM Commissioning Support Unit",
"identifier": {
"legalName": "Arden & GEM Commissioning Support Unit"
},
"address": {
"locality": "Derby",
"postalCode": "DE1 3QT",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody",
"mediationBody",
"reviewContactPoint"
]
}
],
"buyer": {
"id": "GB-FTS-16975",
"name": "NHS England - Specialised Commissioning)"
},
"language": "en"
}